PL2797929T3 - Nowy analog rapamycyny - Google Patents
Nowy analog rapamycynyInfo
- Publication number
- PL2797929T3 PL2797929T3 PL12806101T PL12806101T PL2797929T3 PL 2797929 T3 PL2797929 T3 PL 2797929T3 PL 12806101 T PL12806101 T PL 12806101T PL 12806101 T PL12806101 T PL 12806101T PL 2797929 T3 PL2797929 T3 PL 2797929T3
- Authority
- PL
- Poland
- Prior art keywords
- rapamycin analogue
- novel rapamycin
- novel
- analogue
- rapamycin
- Prior art date
Links
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical class C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1122305.4A GB201122305D0 (en) | 2011-12-23 | 2011-12-23 | Novel compound |
| EP12806101.7A EP2797929B1 (en) | 2011-12-23 | 2012-12-21 | Novel rapamycin analogue |
| PCT/GB2012/053228 WO2013093493A1 (en) | 2011-12-23 | 2012-12-21 | Novel rapamycin analogue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2797929T3 true PL2797929T3 (pl) | 2018-10-31 |
Family
ID=45573035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12806101T PL2797929T3 (pl) | 2011-12-23 | 2012-12-21 | Nowy analog rapamycyny |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9382266B2 (enExample) |
| EP (1) | EP2797929B1 (enExample) |
| JP (1) | JP6268341B2 (enExample) |
| DK (1) | DK2797929T3 (enExample) |
| ES (1) | ES2664246T3 (enExample) |
| GB (1) | GB201122305D0 (enExample) |
| NO (1) | NO2797929T3 (enExample) |
| PL (1) | PL2797929T3 (enExample) |
| WO (1) | WO2013093493A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201122305D0 (en) | 2011-12-23 | 2012-02-01 | Biotica Tech Ltd | Novel compound |
| AU2018219317A1 (en) * | 2017-02-10 | 2019-09-26 | Mount Tam Therapeutics, Inc. | Rapamycin analog |
| WO2019157363A2 (en) * | 2018-02-09 | 2019-08-15 | Mount Tam Therapeutics, Inc. | Rapamycin analog for prevention and/or treatment of cancer |
| WO2019157374A1 (en) * | 2018-02-09 | 2019-08-15 | Mount Tam Therapeutics, Inc. | Rapamycin analog for prevention and/or treatment of neurodegenerative conditions |
| US20210369684A1 (en) * | 2018-02-09 | 2021-12-02 | Torcept Therapeutics, Inc. | Rapamycin analog for prevention and/or treatment of neurodegnerative conditions |
| DE102020203224A1 (de) | 2020-03-12 | 2021-09-16 | Heinrich-Heine-Universität Düsseldorf | Inhibition von FKBP1A zur Therapie des Triple-negativen Mammakarzinoms |
| EP4118431A1 (de) | 2020-03-12 | 2023-01-18 | Heinrich-Heine-Universität Düsseldorf | Inhibition von fkbp1a zur therapie des triple-negativen mammakarzinoms |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA737247B (en) | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
| US3993749A (en) | 1974-04-12 | 1976-11-23 | Ayerst Mckenna And Harrison Ltd. | Rapamycin and process of preparation |
| US4475196A (en) | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5023262A (en) | 1990-08-14 | 1991-06-11 | American Home Products Corporation | Hydrogenated rapamycin derivatives |
| US5221670A (en) | 1990-09-19 | 1993-06-22 | American Home Products Corporation | Rapamycin esters |
| US5138051A (en) | 1991-08-07 | 1992-08-11 | American Home Products Corporation | Rapamycin analogs as immunosuppressants and antifungals |
| JPH06502659A (ja) | 1991-05-31 | 1994-03-24 | ファイザー インク | 免疫抑制剤としてのラパマイシンプロドラッグの使用 |
| ZA935112B (en) | 1992-07-17 | 1994-02-08 | Smithkline Beecham Corp | Rapamycin derivatives |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| GB9221220D0 (en) | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
| US5349060A (en) * | 1993-01-07 | 1994-09-20 | American Home Products Corporation | Rapamycin 31-ester with N,N-dimethylglycine derivatives useful as immunosuppressive agents |
| GB9302016D0 (en) | 1993-02-02 | 1993-03-17 | Sandoz Ltd | Compounds |
| GB9318144D0 (en) | 1993-09-01 | 1993-10-20 | Sandoz Ltd | Organic compounds |
| US5373014A (en) | 1993-10-08 | 1994-12-13 | American Home Products Corporation | Rapamycin oximes |
| US5391730A (en) | 1993-10-08 | 1995-02-21 | American Home Products Corporation | Phosphorylcarbamates of rapamycin and oxime derivatives thereof |
| US5378836A (en) | 1993-10-08 | 1995-01-03 | American Home Products Corporation | Rapamycin oximes and hydrazones |
| JP3745772B2 (ja) | 1993-12-17 | 2006-02-15 | ノバルティス アクチエンゲゼルシャフト | 免疫抑制剤として有用なラパマイシン誘導体 |
| US5362718A (en) | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
| US5563145A (en) | 1994-12-07 | 1996-10-08 | American Home Products Corporation | Rapamycin 42-oximes and hydroxylamines |
| JP3226545B2 (ja) | 1995-06-09 | 2001-11-05 | ノバルティス・アクチエンゲゼルシャフト | ラパマイシン誘導体 |
| US5780462A (en) | 1995-12-27 | 1998-07-14 | American Home Products Corporation | Water soluble rapamycin esters |
| ES2182112T3 (es) | 1996-07-30 | 2003-03-01 | Novartis Ag | Composiciones farmaceuticas para el tratamiento del rechazo de transplantes y de estados autoinmunes o inflamatorios, que comprenden ciclosporina a y 40-o-(2-hidroxietil)-rapamicina. |
| US6015815A (en) | 1997-09-26 | 2000-01-18 | Abbott Laboratories | Tetrazole-containing rapamycin analogs with shortened half-lives |
| US6776796B2 (en) | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
| BR0312691A (pt) * | 2002-07-16 | 2005-05-10 | Biotica Tech Ltd | Métodos para converter uma cepa hospedeira em uma cepa recombinante, para gerar uma cepa recombinante contendo agrupamento biossintéticos, para produzir um análogo de um ligando de fbkp, para construir uma coleção de colÈnias de cepas recombinantes e para preparar uma coleção combinatorial de ligando de fkbp, coleção de análogos de ligando fbkp, cepa recombinante, método para gerar análogos de ligandos de fbkp, composto, e, uso do mesmo |
| GB0417852D0 (en) | 2004-08-11 | 2004-09-15 | Biotica Tech Ltd | Production of polyketides and other natural products |
| GB0504994D0 (en) | 2005-03-11 | 2005-04-20 | Biotica Tech Ltd | Novel compounds |
| CN101836980A (zh) * | 2005-03-11 | 2010-09-22 | 比奥蒂卡科技有限公司 | 39-去甲氧基雷帕霉素及其类似物的医药用途 |
| GB0504995D0 (en) * | 2005-03-11 | 2005-04-20 | Biotica Tech Ltd | Use of a compound |
| WO2010004304A1 (en) * | 2008-06-17 | 2010-01-14 | Biotica Technology Limited | Novel compounds and methods for their production |
| GB201122305D0 (en) | 2011-12-23 | 2012-02-01 | Biotica Tech Ltd | Novel compound |
-
2011
- 2011-12-23 GB GBGB1122305.4A patent/GB201122305D0/en not_active Ceased
-
2012
- 2012-12-21 WO PCT/GB2012/053228 patent/WO2013093493A1/en not_active Ceased
- 2012-12-21 US US14/367,181 patent/US9382266B2/en active Active
- 2012-12-21 ES ES12806101.7T patent/ES2664246T3/es active Active
- 2012-12-21 DK DK12806101.7T patent/DK2797929T3/en active
- 2012-12-21 PL PL12806101T patent/PL2797929T3/pl unknown
- 2012-12-21 JP JP2014548200A patent/JP6268341B2/ja not_active Expired - Fee Related
- 2012-12-21 NO NO12806101A patent/NO2797929T3/no unknown
- 2012-12-21 EP EP12806101.7A patent/EP2797929B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| NO2797929T3 (enExample) | 2018-07-14 |
| US9382266B2 (en) | 2016-07-05 |
| EP2797929A1 (en) | 2014-11-05 |
| GB201122305D0 (en) | 2012-02-01 |
| WO2013093493A1 (en) | 2013-06-27 |
| JP6268341B2 (ja) | 2018-01-31 |
| ES2664246T3 (es) | 2018-04-18 |
| EP2797929B1 (en) | 2018-02-14 |
| US20150210714A1 (en) | 2015-07-30 |
| DK2797929T3 (en) | 2018-05-14 |
| JP2015502973A (ja) | 2015-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3798230T3 (en) | Terapeutiske antistoffer | |
| ZA201306552B (en) | Dispiropyrrolidine derivative | |
| EP2675329A4 (en) | MAINTAINING OVEN | |
| EP2755962A4 (en) | AZAINDAZOLES | |
| EP2715659A4 (en) | ABOUT FEED | |
| EP2702964A4 (en) | STENT | |
| EP2754063A4 (en) | EXTENSIBILITY OF THE SMB2 PROTOCOL | |
| EP2723631A4 (en) | QUADFOILER | |
| EP2776444A4 (en) | dihydropteridinones | |
| SG11201401398XA (en) | Stent | |
| AP2014007621A0 (en) | 2-Thiopyrimidinones | |
| EP2684545A4 (en) | STENT | |
| EP2689752A4 (en) | STENT | |
| EP2687531A4 (en) | TETRAHYDROCARBOLINE DERIVATIVE | |
| EP2695208A4 (en) | MICRO-THERMOCOUPLE | |
| PL2797929T3 (pl) | Nowy analog rapamycyny | |
| EP2740730A4 (en) | DIBENZOOXEPINE DERIVATIVE | |
| GB201119167D0 (en) | Novel bachteriophages | |
| IL233001A0 (en) | New iso-ergoline histories | |
| DK2770906T3 (en) | Applanationstonometer | |
| EP2713728A4 (en) | NEW ANTIBIOTICS | |
| GB201105120D0 (en) | Analogue filter | |
| GB201100001D0 (en) | TidySqueeze2 | |
| AU5026P (en) | Goldstrike Agapanthus inapertus | |
| AU4540P (en) | BUNNAN Baloskion tetraphyllum |